Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
24-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #52579
advertisement
Zhong H
26
Showing records 1 to 25 |
Display all abstracts from
Zhong H
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Tang Y
Heliyon
2024; 10: e25164
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Liao J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Lin J
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lai Z
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Deng W
International immunopharmacology
2024; 126: 111287
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Gao Y; Yu X
Heliyon
2024; 10: e25164
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Liao J
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Ke D
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lin J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Zhong H
Heliyon
2024; 10: e25164
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang W
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Gong G
Heliyon
2024; 10: e25164
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Cui L
International immunopharmacology
2024; 126: 111287
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Mei F
Heliyon
2024; 10: e25164
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Qin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Zhong H; Huang K
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Chen Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
118776
Novel diagnostic indicators for acute angle closure secondary to lens subluxation based on anterior segment and lens parameters
Fan Z; Shi Y
Heliyon
2024; 10: e25164
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Hu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Jiang L; Chen Q
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Cheng Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Xu F
International immunopharmacology
2024; 126: 111287
118313
Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Jiang L; Cui L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
2024; 170: 116042
117189
BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Tang F
International immunopharmacology
2024; 126: 111287
«
1
2
»
Issue
24-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement